| Catalog Number |
46813 |
| Medical Device Problem Code |
Occlusion Within Device (1423)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
06/12/2017
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The product was unavailable for return.Therefore an evaluation of the device performance was not possible.A review of the manufacturing records showed no anomalies.All valves are 100% tested at the time of manufacture.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
It was reported to medtronic neurosurgery that the device was tested intra-operatively for flow.According to the report, during the process, it was found to be preventing any flow of fluid through the valve.Reportedly, a new device was used which when tested, it demonstrated normal flow.
|
| |
|
Additional Manufacturer Narrative
|
|
The returned valve was patent.Therefore the conditions of the complaint could not be duplicated by laboratory personnel.The valve met the requirements for siphon, reflux, pressure-flow, preimplantation, and leak testing.There was proteinaceous debris observed within the interior of the valve.Debris within the valve may hold pressure-flow controlling mechanisms open affecting the flow of fluid through the valve.The instructions for use (ifu) that accompany the device caution that ¿shunt obstruction may occur in any of the components of the shunt system.The system may become occluded internally due to tissue fragments, blood clots, tumor cell aggregates, bacterial colonization, or other debris.¿ a review of the manufacturing records showed no anomalies.All valves are 100% tested at the time of manufacture.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|